Aster DM Healthcare Limited has informed the Exchange about receipt of listing approval
ASTERDM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aster DM Healthcare has received listing approval from BSE and NSE for 1,86,07,969 equity shares (face value Rs. 10 each) that were allotted on a preferential basis at a premium of Rs. 446.33 per share. These shares were issued to two non-promoter entities — BCP Asia II TopCo IV Pte. Ltd and Centella Mauritius Holdings Limited — likely as part of an earlier fundraising. NSE gave its in-principle approval on May 29, 2025, and BSE issued its formal listing approval on June 5, 2025. The company now needs to complete depository (NSDL/CDSL) credit formalities before trading in these new shares can actually begin. The allotment follows prior intimations from March 13, 2025 and April 16, 2025, indicating this is the final step in a process that began several months ago.
This is a procedural update — the preferential shares had already been allotted earlier, so the dilution to existing shareholders has already happened. Once trading begins, the float of Aster DM shares on exchanges will increase by approximately 1.86 crore shares, which may create some short-term supply pressure but the capital raise itself is old news for the stock.